Table 1.
Multivariate Analysis for Patients Included in the TMA
| Characteristic | Frequency count | Total frequency, % |
|---|---|---|
| Histology | ||
| ADC | 192 | 58.72 |
| SCLC | 26 | 7.95 |
| SCC | 109 | 33.33 |
| Sex | ||
| NA | 26 | 7.95 |
| Female | 162 | 49.54 |
| Male | 139 | 42.51 |
| Race | ||
| NA | 26 | 7.95 |
| Caucasian | 265 | 81.04 |
| Other | 36 | 11.01 |
| Type of smoker | ||
| NA | 26 | 7.95 |
| Current | 82 | 25.08 |
| Former | 120 | 36.70 |
| Never | 97 | 29.66 |
| Unknown | 2 | 0.61 |
| Pathologic M | ||
| NA | 26 | 7.95 |
| M0 | 295 | 90.21 |
| M1 | 6 | 1.83 |
| Pathologic N | ||
| NA | 26 | 7.95 |
| N0 | 212 | 64.83 |
| N1 | 55 | 16.82 |
| N2 | 34 | 10.40 |
| Pathologic T | ||
| NA | 26 | 7.95 |
| T1 | 114 | 34.86 |
| T2 | 160 | 48.93 |
| T3 | 16 | 4.89 |
| T4 | 11 | 3.36 |
ADC, adenocarcinoma; NA, not analyzed (low target expression); SCC, squamous cell carcinoma; SCLC, small cell lung cancer; TMA, tissue microarray.